Eric K Rowinsky Biogen Inc. (BIIB) insider trading activity

BIIB Quotes by TradingView

Eric K Rowinsky is Director of BIOGEN INC.. Currently has a direct ownership of 21,969 shares of BIIB, which is worth approximately $3.3 Million. The most recent transaction as insider was on Jun 21, 2024, when has been sold 1,340 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 22K
0% 3M change
8.9% 12M change
Total Value Held $3.3 Million

Eric K Rowinsky Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 21 2024
BUY
Grant, award, or other acquisition
-
1,340 Added 5.75%
21,969 Common Stock
Feb 15 2024
BUY
Open market or private purchase
$101,255 $222.54 p/Share
455 Added 2.16%
20,629 Common Stock
Jun 26 2023
BUY
Grant, award, or other acquisition
-
960 Added 4.54%
20,174 Common Stock
Jun 15 2022
BUY
Grant, award, or other acquisition
-
1,370 Added 6.66%
19,214 Common Stock
Jul 01 2021
BUY
Grant, award, or other acquisition
-
775 Added 4.16%
17,844 Common Stock

Also insider at

FBIO
Fortress Biotech, Inc. Healthcare
Director
VSTM
Verastem, Inc. Healthcare
Director
EKR

Eric K Rowinsky

Director
New York, NY

Track Institutional and Insider Activities on BIIB

Follow BIOGEN INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BIIB shares.

Notify only if

Insider Trading

Get notified when an Biogen Inc. insider buys or sells BIIB shares.

Notify only if

News

Receive news related to BIOGEN INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on BIIB